Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis

Abstract

These results suggest that although IL-23 may have pathogenic activity in a proportion of patients with late-stage RA, it is not abundantly produced in this inflammatory tissue, nor does it have a dominant role in all patient tissues analysed.